ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study
Abstract Novel druggable targets are warranted for inflammatory bowel disease (IBD) treatment. We aimed to identify novel circulating proteins with causal associations with the risk of IBDs and provide potential therapeutic targets for IBD treatment. We performed a two‐sample Mendelian randomization...
Saved in:
Main Authors: | Jiarui Mi (Author), Xia Wu (Author), Xiaoyin Bai (Author), Yang Yang (Author), Hong Yang (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic druggable genome‐wide Mendelian randomization identifies therapeutic targets for sarcopenia
by: Kang‐Fu Yin, et al.
Published: (2024) -
Comprehensive mendelian randomization reveals atrial fibrillation-breast cancer relationship and explores common druggable targets
by: Fenglin Qi, et al.
Published: (2024) -
Association of Antidiabetic Drug Target Genes with Inflammatory Bowel Disease: A Mendelian Randomization Study
by: Qing X, et al.
Published: (2024) -
Two-sample Mendelian randomization analysis evaluates causal associations between inflammatory bowel disease and osteoporosis
by: Zhujiang Dai, et al.
Published: (2023) -
Assessing the associations of inflammatory bowel disease and hepatitis B virus infections with two-sample bidirectional mendelian randomization
by: Ping Han, et al.
Published: (2024)